top
Search terms
Results 1 - 2 of 2 - ordered by :
Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial
Ehjournal

Of GPI-treated patients, the median time from symptom onset to GPI administration was 180 min (25th, 75th percentile: 130, 258); 1125 received the agent prior to arriving in the catheterization ...

European Heart Journal, Huber, Kurt, Holmes, David R., van 't Hof, Arnoud W., Montalescot, Gilles, Aylward, Philip E., Betriu, G. Amadeo, Widimsky, Petr, Westerhout, Cynthia M., Granger, Christopher ...

Date : 01/07/2010 Item size : 346188 bytes
Use of glycoprotein IIb/IIIa inhibitors in primary percutaneous coronary intervention: insights from the APEX-AMI trial
Ehjournal

Of GPI-treated patients, the median time from symptom onset to GPI administration was 180 min (25th, 75th percentile: 130, 258); 1125 received the agent prior to arriving in the catheterization ...

European Heart Journal, Huber, Kurt, Holmes, David R., van 't Hof, Arnoud W., Montalescot, Gilles, Aylward, Philip E., Betriu, G. Amadeo, Widimsky, Petr, Westerhout, Cynthia M., Granger, Christopher ...

Date : 01/07/2010 Item size : 352818 bytes